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Abstract  
 
Objective: The purpose of this study was to evaluate the reliability and validity of body 
composition measurements in morbidly obese adults. These measurements were obtained 
using multiple-frequency bioelectrical impedance analysis (BIA) under different 
conditions: pre and post pedicure for removal of callosities, with and without InBody 
electrolyte wipes and custom-built axillary pads. For validity purposes, body composition 
measurements from BIA were compared with measurements from air displacement 
plethysmography (ADP).  
 
Design: Repeated measures, clinical intervention study testing the reliability and validity 
of BIA in the morbidly obese. 
  
Subjects: 36 morbidly obese patients from St. Olav University Hospital (13 males, 23 
females, aged 28-70, BMI 41.6 ± SD 4.3) with moderate to severe callosities. 
 
Measurements: Body composition was assessed as percentage of body fat (%BF) using 
ADP and multiple-frequency BIA. Body weight and height measurements were also 
taken; plantar callosities were photographed and scored for severity using a 5-point scale 
by an authorized podiatrist. BIA measurements were taken before and after removal of 
plantar callosities (pedicure), and with or without InBody electrolyte wipes and custom-
built axillary pads.  
 
Results: The study participants’ %BF measurements were found to be significantly 
higher with axillary pads than without (p < .001). No statistically significant differences 
were found in %BF measurements pre to post pedicure, and with vs. without usage of 
electrolyte wipes. There were also no statistically significant differences in %BF between 
BIA and ADP.  
 
Conclusion: Multiple-frequency BIA is a valid method for estimating %BF in morbidly 
obese adults. Arm posture appears to have a significant impact on %BF assessed by BIA, 
as opposed to the presence of plantar callosities and usage of InBody electrolyte wipes, 
which showed no significant effect. Further examination of the effect of skin contact 
between the arm and trunk on the accuracy of BIA measurements is warranted. For 
clinical and scientific purposes, standardization of BIA measurement procedures is 
recommended. 
 
Keywords: bioelectrical impedance analysis; air displacement plethysmography; body 
composition; morbid obesity; callosities 
 
 
This thesis has been written using the format and guidelines provided by the International 
Journal of Obesity for submission purposes. 
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Introduction 
 
More and more people are becoming overweight and obese due to an 
overconsumption of energy dense, nutrient poor, highly caloric foods rich in sugars, oils, 
and animal fats (1). This, combined with a dramatic reduction in physical activity due to 
the popularity of sedentary activities, the presence of various modes of transportation, 
and increasing urbanization has made the obesity epidemic one of the greatest public 
health challenges of the 21st century (2). The World Health Organization (WHO) defines 
obesity as an abnormal or excessive fat accumulation that presents a risk to health and is 
most commonly measured by body mass index (BMI), an index of weight-for-height 
calculated from a person’s weight in kilograms divided by the square of his height in 
meters (kg/m2) (3). The prevalence of obesity is staggering, as the WHO estimates that 
more than 1.4 billion adults are currently overweight (BMI 25-29.9 kg/m2) and more than 
half a billion are obese (BMI ≥ 30.0 kg/m2) (4).  The WHO further reports that 65% of the 
world’s population lives in countries where overweight and obesity are linked to more 
deaths than underweight (3). It is considered the fifth leading risk for global preventable 
deaths (3). Obesity is known to cause physical disabilities as well as psychological 
problems; the presence of excess weight on the human body increases a person’s risk for 
developing adverse health effects from non-communicable diseases such as diabetes, 
cancer, and cardiovascular diseases (2). In turn, the presence of one or more of these non-
communicable diseases increases the risk of premature death and reduces life expectancy  
(5, 6).  
 
The WHO has further subdivided obesity into three classes, where BMI 30 – 34.9 
kg/m2 corresponds to class 1 or moderate obesity, BMI 35-39.9 kg/m2 is indicative of 
class 2 or severe obesity, and ≥ 40 kg/m2 is considered class 3 or very severe obesity (7). 
As the prevalence of obesity continues to increase, many parts of the world are 
progressively facing a rise in the number of people who fall under obesity class 2 and 3 
(8). This is of great concern, especially because severe (morbid) obesity is associated 
with a significant reduction in life expectancy (6). The National Health and Nutrition 
Examination Surveys (NHANES Mortality Studies) conducted a study that looked at the 
life expectancy of Caucasians and found that the average years of life lost (YLL) for men 
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and women with BMI ≥ 35 kg/m2 were around 9 to 13, respectively, whereas those who 
were in the lower range of BMI (<17 to 19 kg/m2) had YLL values that ranged from 1 to 
9 (9). Since morbid obesity is characterized by large alterations in body compartments 
when compared to overweight or non-obese individuals, there is a need for the evaluation 
of the body composition of severely obese persons (8). There is little published research 
available on what methods of body composition measurement can be used on this 
population (10-13).  
 
Body composition  
 
BMI is often used as a surrogate measurement of body composition in 
epidemiological studies and recommended as a screening tool for the initial clinical 
assessment of obesity due to its simplicity, inexpensiveness, and relatively good 
correlation with body fat (14-16). It has been invaluable for the current obesity 
classification system and its advantages have been utilized across various disciplines (17, 
18). Although BMI has served as a great tool for studying nutritional status, it is not a 
good indicator of body composition because it does not distinguish muscle from fat mass 
(19). The assessment of fat mass and its distribution in the body is critical when 
examining the relationship between adiposity and the risks associated with metabolic 
diseases (diabetes, hypertension, hyperlipidemia) (20). Worryingly, studies have revealed 
that BMI tends to underestimate fatness calculated as body fat percentage (%BF) and 
therefore, in order to correctly identify obese individuals, %BF and waist circumference 
should also be measured (21, 22). 
 
Anthropometric measures are estimated from the densities of fat mass (FM) and 
fat-free mass (FFM) compartments of the body (23). Many studies have reflected upon 
the challenges in making anthropometric assessments on the severely obese (8). 
Traditional assessment methods that have often been used to measure body composition 
in non-obese, overweight, and obesity class 1 individuals, have appeared to be either 
inaccurate or inappropriate for practical reasons when measuring individuals in obesity 
class 2 or higher (13). Though measuring height can easily be done using a stadiometer, 
weighing morbidly obese persons can be difficult because scales need to provide valid 
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and reliable measurements while having platforms that are wide enough for them to 
comfortably stand (8). Densitometry and Dual-energy X-ray absorptiometry (DEXA) 
have been used as reference techniques for body composition assessment in overweight 
and obesity class 1 individuals, but those with class 2 obesity or higher frequently exceed 
the weight limits of these instruments and in certain situations have not been able to 
physically fit into the measurement compartment (24, 25). Air displacement 
plethysmography (ADP), using the commercial system BodPod (COSMED, Italy), is 
another method commonly utilized to measure body composition in pregnant women, 
children, and the severely obese (25). This method is often employed because it is user-
friendly and has demonstrated to have good agreement with body composition 
measurements derived from hydrostatic weighing (HW), a method seen as the “gold 
standard” for measuring body composition (26, 27). Body volume is measured using 
Boyle’s law, where body volume is equal to the reduction of volume in the chamber (28). 
During measurement, air is displaced when an individual is sitting in the sealed chamber. 
Body volume, combined with body weight (mass), is used to determine body density so 
that %BF and lean body mass (LBM) can be calculated using either the Siri or Brozek 
formula (29). Another technique that has been used to measure body composition in 
severely obese individuals is bioelectric impedance (BIA) (8, 12, 30). 
 
Bioelectrical impedance  
 
Since BIA was introduced in the 1980s, it has become an increasingly popular 
tool for estimating body composition because it is user-friendly, noninvasive, relatively 
inexpensive, portable, and can be performed across a wide range of subjects (30-32). It 
has been often used to predict body composition components such as fat free mass 
(FFM), total body water (TBW) and body fat. In BIA, a small alternating electrical 
current is applied to the body so that the resistance or impedance of the body to the 
current can be measured as it passes across body tissues (33). Single frequency BIA 
technology at 50 kHz can determine the impedance of body tissues. Impedance provides 
a valid estimate of TBW that can be used to estimate FFM and adiposity (31, 32). 
According to Hu, the method is based on the principle that the resistance applied to an 
alternating electrical current is a function of tissue composition (24). The greater the FFM 
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of an individual, the faster the current will pass through; thus, the greater the fatty tissue, 
the greater the resistance is to the current (24). Under most conditions, single frequency 
BIA can provide reliable estimates of TBW as it can serve as a practical technique for the 
analysis of body composition in healthy individuals and in those with conditions where 
major water disturbances are not eminent (27). However, it is important to note that BIA 
values can be affected by a several factors, including: body position, hydration status, 
consumption of food and beverages, ambient air and skin temperature, recent physical 
activity, and conductance of the examining table (31, 34). Therefore, the standardization 
of measurement conditions is required in order to obtain accurate, valid, and reliable data 
(31, 34).  
 
The quality of BIA has improved greatly over the last years with the introduction 
of a multiple frequency BIA (24). An example of a multi-frequency impedance body 
composition analyzer is InBody 720 (Biospace, Korea), an instrument that estimates body 
composition by using a segmental, eight-point tactile electrode method and is able to 
measure resistance and reactance at multiple frequencies (30). The InBody 720 consists 
of a platform with an integrated scale, hand and feet electrodes, and a display operation 
unit. InBody 720 is currently being used in clinical practice among obese individuals in 
many parts of the world, including Norway (35). More studies are warranted on the 
reliability and validity of BIA in the severely obese demographic, as the available 
literature has shown multiple shortcomings. The percentage of FM (BF % > 30%) is 
often underestimated and FFM overestimated when compared to DEXA (36-38).  
 
The underestimation of the percentage of FM using BIA may be caused by the 
lack of standardization during BIA measurements. For instance, the InBody 720’s manual 
instructs the individual being measured (the examinee) to form an angle of 15° between 
the arms and sides while holding on to the hand electrode (39). The manual, however, 
does not provide specific instructions on how this is to be done, nor does it explain the 
significance of holding such an angle. The InBody 720 manual also recommends the use 
of InBody electrolyte wipes when an error message appears and the analyzer stops the 
test due to an incorrect standing posture or due to the examinee’s dry palms and soles. 
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The manual simply instructs the user to wet the palms and soles of the feet prior to re-
initiating the test. The lack of information provided and the instructions given for this 
procedure are unclear and difficult to standardize. Standardization of BIA procedures is 
of high clinical importance and needs to be explored further. 
 
Callosity 
 
As mentioned earlier, some of the factors that may affect BIA measurement 
values include hydration status and skin temperature. While measurements are taken 
using BIA instruments such as InBody 720, the skin becomes occluded from coming into 
contact with the instrument’s metal electrodes (40) Thus, the rate of water accumulation 
at the contact sites may be affected during the BIA procedure, as skin contact with the 
BIA instrument introduces systematic error by disrupting natural transpiration (40, 41). 
The rate of water accumulation in the stratum corneum is further exacerbated by the 
presence of callosities, as new stratum corneum that is formed underneath calluses have 
been found to be less hydrated than normal (41). ‘Callosity’, or hyperkeratotic lesions, is 
an umbrella term for corns and calluses (42). Callosities are formed when the skin 
becomes irritated by either internal or external pressure and results in the development of 
a corny layer of epithelium (40). 
 
 Plantar callosity (hyperkeratosis) is considered one of the most common skin 
disorders that affects obese persons (43). Callosities in the foot are often painful and have 
been associated with reduced walking speed, impaired balance, and difficulty in 
ascending and descending stairs (44). Garcia-Hidalgo and colleagues (1999) conducted a 
cross-sectional study on 156 obese patients belonging to classes 1-3 and concluded that 
plantar hyperkeratosis should be considered as a cutaneous stigma of severe obesity (45). 
Obese individuals are known to have difficulty in doing daily activities such as bathing, 
dressing, and giving themselves pedicures because their excess weight lowers their 
mobility, flexibility, and dexterity (46). The reduction in mobility and flexibility poses 
challenges for obese persons in maintaining hygiene. As pedicures can be troublesome 
for those who have poor dexterity, it may be helpful for them to obtain professional 
assistance in managing corns and calluses (47). Garcia-Hidalgo and colleagues (1999) 
	  	   11	  
have also claimed that the formations of plantar callosities are likely to have resulted 
from pressure due to excess weight (45). The challenges of maintaining proper foot 
hygiene may be worsened due to the social stigmatization of the obese population. The 
act of being socially marginalized may contribute to the shift in hygienic standards by 
lowering obese individuals’ motivation for maintaining body hygiene. This reduction in 
the upkeep of body hygiene may intensify callosity-related problems in this population 
(45). To our knowledge, no study has looked at the potential impact of plantar callosities 
on the reliability of BIA measurements. Due to the lack of knowledge on this topic, 
further research is warranted. 
 
This study’s aims and hypotheses will be discussed on the next page. 
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Aims and hypotheses 
 
Purpose of study 
  
The purpose of this study was to evaluate the reliability and validity of body composition 
measurements in morbidly obese adults obtained using BIA.  
 
Primary aims:  
 
• To evaluate whether plantar callosities have an impact on the reliability of body 
composition measurements in morbidly obese adults obtained by BIA using the 
InBody720 (Biospace, Korea).  
 
• To evaluate whether arm posture has an impact on the reliability of body 
composition measurements in morbidly obese adults obtained by BIA using 
custom-made axillary pads made of Plastazote®, angled at 15° (15° arm posture 
is recommended by the InBody 720 manual). 
 
• To evaluate whether the use of InBody electrolyte wipes (recommended for use 
by InBody) has an impact on the body composition measurements in morbidly 
obese adults obtained by BIA.  
 
Secondary aim: 
 
• To evaluate the validity of body composition measurements obtained through BIA 
in morbidly obese adults by comparing BIA results with those acquired by air 
displacement plethysmography (ADP), using BodPod (COSMED, Italy), as the 
gold standard. 
Hypotheses 
 
Primary hypotheses: 
 
• Plantar callosities have an impact on the reliability of body composition 
measurements obtained using BIA in morbidly obese adults. 
 
• Arm posture has an impact on the reliability of body composition measurements 
obtained using BIA in morbidly obese adults. 
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• InBody electrolyte wipes have an impact on the reliability of body composition 
measurements obtained using BIA in morbidly obese adults. 
 
Secondary hypothesis: 
 
•  BIA underestimates the percent body fat of morbidly obese adults when 
compared with ADP. 
 
Methods 
 
Study design 
 
This study used a repeated measures design, where body composition was 
assessed using BIA before and after interventions under various circumstances. Pre and 
post intervention BIA results were compared to one another and to results obtained by 
ADP. All of the participants were treated as one group, tested under all conditions, and 
served as their own controls.  
 
Participants 
 
Inclusion criteria: Adults with class 2 and 3 obesity (BMI ≥ 35.00 kg/m2) and with 
moderate to severe callosities (as assessed by podiatrist affiliated with the study on a 
scale out of 5, participants with callosities ranging from 3-5 were included).  
 
Exclusion criteria: Intractable plantar keratosis (IPK) – painful plantar calluses located 
under the metatarsal heads	   (40). Individuals who were pregnant or were suffering from 
diseases that cause water retention (edema, renal insufficiency, hypertension, etc.) were 
also excluded from this study. 
 
Main outcome variables 
 
Data collected: Body weight and height, body composition using BIA and ADP, sole and 
heel of foot (through photograph). 
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Detailed description of the study 
 
36 study participants (13 males, 23 females, aged 28 - 70) were recruited from the 
Obesity Outpatient Clinic of St. Olavs University Hospital in Trondheim, Norway from 
September 2012 until March 2013. All participants were patients of the Outpatient Clinic 
and were recruited either during scheduled checkups or through courses offered by the 
Outpatient Clinic on obesity care for patients undergoing bariatric surgery. Initial data 
was collected at the Outpatient Clinic from severely obese patients who were interested 
in this study, by nurses working at the Outpatient Clinic. The nurses took photographs of 
the soles of the feet of these individuals; these photographs were then given to an 
authorized podiatrist affiliated with the study for an eligibility assessment. Study 
participants whose feet were given a severity score of 3 or higher were included in the 
study. Information regarding the study was given to the participants who had fulfilled the 
eligibility criteria at the start of the study. Individuals who sought to participate in this 
study were given written information about the study and a consent form. This study was 
approved by REK, the Norwegian Regional Medical Ethics Committee (REK Midt Ref 
no. 2012/1018). Participation in the study was voluntary and involved no known risks as 
these tests have been proven to be non-invasive to the target population. Study 
participants were able to withdraw their consent to participate at any time without stating 
any particular reason.  
 
Procedure 
 
The intervention took place over a span of two consecutive days. During both 
days, participants were given an appointment to meet at the Obesity Outpatient Clinic of 
St. Olavs University Hospital, having fasted and emptied bladder before testing to 
achieve optimal test accuracy and for standardization purposes. On Day 1, study 
participants first had their feet photographed by the researcher, had their height measured 
using a stadiometer, and then were measured by BIA (InBody 720) using form-fitted 
clothing (undergarments). Four sets of body composition measurements were taken using 
the InBody 720 on Day 1.  
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During the first measurement, the participant was asked to step onto the InBody 
720 and have their arms extended out at approximately 15° arm posture (InBody 
recommended arm posture).  For the second measurement, the participant was given 
axillary pads made out of Plastazote®, a non-conductive, water resistant material, that 
were custom built for the study to help participants hold their arms out at an exact 15° 
angle (see Figure 1). This test was performed in order to determine if the recommended 
15° posture is crucial for obtaining precise measurements. The InBody 720 was weight-
adjusted to compensate for the weight of the axillary pads.  The third and fourth 
measurements were very similar to the first and second. However, in addition, 
participants were also asked to moisten the palms of their hands and soles of their feet 
with an InBody electrolyte tissue that was recommended for usage when taking 
measurements using InBody720. These wipes were designed by Biospace to help moisten 
the hands and feet of those whose palms and soles are too dry or have too much hard 
skin. However, for the purposes of this study, we have assumed that all participants had 
dry skin and required their palms and soles to be wiped with electrolyte wipes, regardless 
of the presence of error messages. 
 
Figure 1. Study participant being measured on InBody 720 using custom-made 
axillary pads 
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Following the completion of InBody 720 measurements, each participant 
underwent one final measurement using air displacement plethysmography (ADP) 
performed by the BodPod. Once the researcher had computed patient information and 
completed volume calibration, the study participant was asked to take a body weight 
measurement by stepping on a scale connected to the BodPod and then sit inside the 
BodPod chamber using form-fitted clothing (undergarments) and a swim cap for two 50-
second body volume measurement periods. Once the participants had been measured, 
they were allowed to break their fast and eat breakfast provided by the study. Following 
breakfast, the study participants were sent over to the podiatrist (fotterapeut) located at 
the St. Olavs University Hospital campus where calluses and corns were removed 
(pedicure). This procedure lasted for approximately one hour.  
 
During Day 2, the study participants had their feet photographed again by the 
researcher prior to the measurements on the InBody 720 that were taken again in a fasted 
state (for comparison pre – post pedicure). Body composition measurements taken using 
form-fitted clothing on Day 2 were similar to the third and fourth measurements 
performed on Day 1: two sets of measurements were taken at an arm posture of 15° and 
InBody electrolyte wipes (once with axillary pads and once without). Study participants 
were also served breakfast upon completion of all body composition measurements. 
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Flow chart of study participants undergoing the study 
 
 
 
 
 
 
• Upon approval from REK, Patients of the Obesity Outpatient Clinic at St. Olavs 
University Hospital were informed about the study during checkups or courses offered by 
the Outpatient Clinic. 
• Interested patients were given written information study. 
 
• Patients who signed consent forms had their feet photographed for eligibility assessment. 
• The photographs were evaluated by an authorized podiatrist affiliated with the study. 
 
• Patients who fulfilled the eligibility criteria received appointments to meet with the 
researcher during two consecutive days (October 2012 – March 2013). 
 
Day 2: Participants met having fasted for measurements. 
 
• Photographs of sole and heel of feet were taken for pre and post pedicure 
comparisons, 2 sets of measurements (with and without axillar pads, with InBody 
electrolyte wipes). 
• Breakfast was also provided following Day 2 measurements. 
 
Day 1: Participants met the researcher at a fasted state for measurements and callosity 
removal  (pedicure). 
 
• Photograph of sole and heel of feet were taken, height measured using a stadiometer,  
• 4 sets of measurements were taken using the InBody720 under different 
circumstances (with and without axillar pads, with and without InBody electrolyte 
wipes). 
• BodPod measurements also taken. 
• Participants broke their fast and ate breakfast provided by study, and received a 
pedicure from the podiatrist. 
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Statistical Analysis 
 
The SPSS statistical package 20.0 (SPSS Inc., IBM Company, Chicago, IL, USA) 
for Macintosh was used for statistical analysis. Data was assessed for normality using 
normal probability plots and the Anderson–Darling test for normality. These assessments 
showed that the data was not normally distributed. Various common transformations for 
data were applied to see if the data could be transformed to have a normal distribution, 
but the transformed data also did not appear normal. Statistical significance was set at  
(p < .05). The following analyses were performed: 
 
 
Limits of Agreement using Bland Altman plots  
 
Limits of agreement for body fat percentage (%BF) measured were visualized 
using Bland-Altman difference plots for all four interventions (pre and post pedicure, 
with and without axillary pads, with and without InBody electrolyte wipes, and BIA and 
ADP). Limits of agreement analyzed using Bland Altman plots are designed primarily to 
look at how two methods of clinical measurements agree with one another statistically 
(48). It is expected that if two methods are designed to measure the same parameter, they 
should produce good correlation. Therefore, even though the plots can provide insight 
into the impact of interventions performed on BIA, it is more beneficial when observing 
how %BF values obtained by BIA agree with the values given by ADP. Bland-Altman 
plots are constructed when the differences between the two methods (y-axis) are 
compared with the averages of the two methods (x-axis). These plots are designed to 
investigate the presence of any systematic differences and to identify potential outliers. 
The mean difference serves as the estimated bias, while the standard deviation of the 
differences is plotted to measure the random fluctuation around the mean.  
 
Wilcoxon signed-rank test with continuity correction 
 
Testing for the effect of interventions was done in order to determine whether the 
difference in %BF was statistically significant for each intervention we performed. Paired 
t-tests were initially conducted due to the nature of the comparisons, however, not all of 
the values were normally distributed. As a result, all differences were treated the same 
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and non-parametric tests were used. Thus, non-parametric Wilcoxon signed rank tests 
with continuity correction were performed. Had paired t-tests been performed, the 
conclusions reached using the Wilcoxon signed-rank test would have been similar at a 
5% significance level.   
 
Linear regression analysis 
 
Linear regression analysis was performed for the %BF measurements obtained 
when the participants were measured using BIA with InBody electrolyte wipes and no 
axillary pads during Day 1 (shown on Table 3 in results section). These measurements 
were used for regression analysis because they were conducted using the 
recommendations given by the InBody720 manual.  Linear regression was used to look 
for tendencies with variables (age, gender, BMI, severity of callosities) that could explain 
the differences in %BF. Additional linear regression analyses were also performed using 
the differences in %BF for each intervention to see if the potential predictors could 
explain the variability. 
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Results  
 
 
Overall characteristics of the participants included in the study can be seen in 
Table 1 below. For measurements obtained with and without axillary pads, the results of 
4 study participants were excluded due to technical difficulties associated with the 
InBody 720 machine (BIA). There was also one participant who was physically unable to 
fit inside the BodPod chamber (ADP) due to his size and thus, measurements were unable 
to be taken for comparative purposes.  
 
Table 1. General characteristics of study participants* 
* Data presented as ± standard deviation 
a Weight and BMI reported were measured using BIA following the equipment guidelines  
(with electrolyte wipes, no pads) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Male Female Total 
Number of 
participants 
13 23 36 
Age (years) 44.8 ± 11.3 46.8 ± 10.6 46.1 ± 10.6 
Height (cm) 181.2 ± 7.1 168.0± 5.7 172.7 ± 8.9 
Weight (kg) a  142.4 ± 19.8 114.6± 12.3 124.6 ± 20.4 
BMI (kg/m2)a   42.5 ± 5.2 40.6 ± 4.0 41.6 ± 4.3 
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The mean percent body fat before and after each BIA intervention can be seen in 
Table 2.  
 
Table 2. Percent body fat (%BF) assessed under different interventions  
Intervention N Mean %BF Standard 
Deviation 
z-scorea p rb 
Pedicure   
 
36 
  -1.71 .09 .29 
 
 
Pre 46.63 6.26    
Post 47.01 5.96    
Difference 0.38 1.06    
Electrolyte wipes  
 
36 
  -0.99 .32 .17 
 No wipes 46.87 5.85    
With wipes 46.63 6.26    
Difference 0.24 1.05    
Axillary pads  
 
32* 
  -4.66 < .001 .82 
 
 
No pads 46.63 6.26    
With pads 47.67 6.01    
Difference 1.04 0.87    
Instruments  
 
35* 
 
  -0.71 .48 .12 
 
 
ADP 47.22 5.42    
BIA 46.63 6.26    
Difference 0.33 3.31    
* Missing values were unobtainable because of technical difficulties and inability for a 
study participant to be measured due to size. 
a Test statistic 
b Effect size 
 
 
The Wilcoxon signed-rank tests revealed that the intervention with axillary pads 
was the only one that resulted in a highly statistically significant difference in %BF 
measurements (p < .001). Percent body fat values were higher for all participants using 
axillary pads than without pads. The effect size, r, for the axillary pads intervention is 
considered extremely large when measured against Cohen’s criteria, where an effect size 
≥ 0.5 is considered as large (49). The effect size for this intervention is also much larger 
than the other three interventions analyzed in this study. The other three interventions did 
not have a statistically significant effect.  
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Bland-Altman plots can be seen in Figure 2 (A-D) below.  
 
Figure 2. A-D: Bland-Altman plots of the different interventions, showing mean 
and ± 2 standard deviations 
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For each one of the plots, it appears that the majority of  the data sets observed 
fall within the limits set at  ± 2 standard deviations. All four figures show a tendency for 
the females in the study to have higher body fat percentages compared to the males. 
There appears to be a clustering of values from female participants who have 50-55 %BF. 
The differences in %BF in all measurements obtained only using BIA (pre and post 
pedicure, with and without wipes, and with and without axillary pads) had a much lower 
variance than when %BF measurements obtained by BIA were compared with those 
obtained by ADP. The standard deviation of %BF values measured by BIA and ADP was 
significantly higher than that of the other three interventions. 
 
Figure 2C depicting the graph of %BF measurements obtained during the axillary 
pad intervention showed a fixed bias, or a systematic difference between the 
measurements. The mean difference, 0.92, is much closer to 1 than 0. This is not the case 
for the other interventions. This observation is echoed by the results of the Wilcoxon 
signed-rank test described below. Unlike Figure 2C, Figure 2A and 2B did not reveal to 
have systematic differences. With the exception of Figure 2C, there appears to be a 
consistent outlier on either side of the standard deviations plotted on all figures. Similar 
to Figure 2A and 2B, Figure 2D also did not depict systematic differences, despite the 
large spread.  
 
Results from the regression analysis performed on %BF values obtained using 
BIA (with electrolyte wipes and no pads) can be seen in Table 3 on the next page. 
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Table 3. Multiple regression analysis of % BF measurements obtained from BIA 
using InBody electrolyte wipes and no axillary pads 
* Unlisted values for male and severity score 5 are not listed because the values have 
been incorporated into the intercept 
Multiple R2: 0.74 (Adjusted R2: 0.69) 
Residual Standard Error: 3.48 with 31 degrees of freedom 
F-statistic: 20.62 with 4 and 3 degrees of freedom, (p <.001).  
 
Linear regression analysis revealed that with a one-unit increase in BMI, %BF 
increased by 0.5 percent points. We can conclude that BMI is significant in predicting 
%BF because the p-value reported is < .001, which is less than the cutoff. Age and 
severity score of callosities do not appear to be significant factors. However, gender 
proved to be an important factor as well, with a (p < .001). On average, the females in 
this study had a %BF that was 11 percent points higher than the males. Overall, the 
regression model fitted with age, BMI, gender, and severity score of callosities accounted 
for 74% of the variability in the data collected. The results from the omnibus F-test 
performed on this data revealed that the model involving the predictors discussed is 
suitable fit for predicting %BF. When the regression analysis was re-done fitted with only 
gender and BMI, the results showed that these two variables alone could explain 72% of 
the variability in the data.  
 
Parameter B Standard 
error of B 
p 95% Confidence interval 
Lower bound     Upper bound 
Intercept 22.32 6.46 .002 9.13 35.51 
Age (years) -0.05 0.05 .37 -0.16 0.06 
Gender       
 Female 10.76 1.26 <.001 8.20 13.33 
BMI (kg/m2) 0.48 0.14 <.001 0.20 0.76 
Severity 
score  
 
     
 3 -0.67 1.43 0.64 -3.59 2.24 
4 0.31 1.35 0.82 -2.44 3.06 
	  	   25	  
As mentioned earlier, further regression analyses were performed on the 
differences for each one of the interventions using the same predictor variables described 
above. The results from the omnibus F-tests performed for all interventions: pre and post 
pedicure, wipes vs. no wipes, axillary pads vs. no axillary pads, and the comparison of 
ADP and BIA proved to be statistically insignificant at (p < .05). For the differences in % 
BF values before and after the pedicure, the regression model fitted with age, BMI, 
gender, and severity score only accounted for 9.3% of the variability in the data collected. 
For the differences in % BF values with and without InBody electrolyte wipes, the 
variables described above explained 6.1% of the variability in the data. For the 
differences in % BF values obtained through ADP and BIA, the predictor variables 
discussed accounted for 5.6% of the variability in the data. The regression analysis 
performed on the difference in %BF using axillary pads and no pads revealed that the 
predictor variables were able to explain 29% of the variability in the data. Despite a 
significantly larger variability explained in this model, none of the predictor variables 
were significant at (p < .001), however, gender and BMI were significant at (p < .05) in 
predicting %BF.  
 
 
Figure 3. Before and after pedicure foot picture of a study participant 
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Discussion 
 
The assessment of body composition in severely obese adults remains 
challenging. The need for a practical, valid, and reliable method to assess body 
composition especially for the morbidly obese is warranted. BIA is user-friendly, 
noninvasive, relatively inexpensive, portable, and can be used on a wide range of 
subjects, however, its validity and reliability is still disputable. Overall, based on our 
findings, it seems that multiple-frequency BIA is a valid method for estimating %BF in 
severely obese adults; the results obtained from BIA in our study population are 
comparable with those obtained by BodPod. Our results also show that plantar callosities 
and the use of InBody electrolyte wipes do not have a statistically significant effect on 
BIA measurements. Arm posture, however, was revealed to be of statistical significance 
when measuring %BF in morbidly obese individuals using the BIA method. Further 
examination of the arm and trunk contact and how this may affect the reliability of BIA 
measurements is warranted. Clinical significance is not contingent upon statistical 
significance; our findings, regardless of statistical status, are of clinical importance and 
should be taken into consideration in clinical settings as well as future research involving 
BIA. 
 
 
Reliability 
Few studies have looked at the reliability of BIA on severely obese individuals. 
Studies that have looked at BIA’s reliability have often recommended further evaluation 
on the standardization of BIA measurements (31, 34). Several factors have been found to 
affect BIA’s body composition values (31, 34). The present study assessed the impact of 
body (arm) position and skin hydration status on BIA measurements.  Arm position was 
assessed using axillary pads, while hydration status of the skin was assessed using 
InBody electrolyte wipes and pedicure to remove callosities.  
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Plantar callosity removal (pedicure) 
BIA is becoming an increasingly popular method for assessing body composition 
in clinical settings. Thus, knowledge on this topic is of high clinical importance, 
especially since hydration status is a key component of BIA and the presence of 
callosities might influence the rate of water retention. As far as we know, the effect of 
plantar callosities on BIA measurements has never been examined. We wanted to explore 
the impact of plantar callosities on the reliability of BIA measurements because the 
presence of callosities suggests that the skin is not normally hydrated. This condition 
potentially causes systematic errors to arise during BIA measurements, where the skin on 
the palms and the soles of the feet come into contact with metal electrodes (40).  
 
To our surprise, the removal of callosities did not have a statistically significant 
effect on %BF. The results of our regression analysis performed on %BF measurements 
before and after callosity removal showed that the severity of callosities do not affect 
body composition measurements obtained using the BIA method. One reason could be 
because the calluses we observed in our study participants had a tendency to form around 
the heel of the foot as well as the sides of the foot, and not so much on the plantar region. 
The InBody 720 platform only uses the plantar area of the foot to read measurements; the 
calluses present on the sides and around the heel of the foot are not involved in the 
measurement.  Therefore, the removal of calluses might not have made much of an 
impact. To the best of our knowledge, no known objective classification system 
measuring the severity of callosities is available. Despite the lack of such a system, we 
had a highly experienced podiatrist that was well qualified to make callosity assessments 
of our study participants’ feet. The podiatrist had decided to evaluate the severity of 
callosities using a scale from 1-5 (5 being most severe) and had given initial assessments 
of the study participants’ feet using photographs. The photographs might not have been 
adequate to fully determine the severity of the calluses. Further statistical analyses were 
performed on participants belonging to a scale of 4 and/or 5 to see if higher severity 
would have an effect on %BF measurements, but the findings were insignificant and 
inconclusive. Despite statistical insignificance, since the results of our intervention 
revealed that callosities do not affect the reliability of BIA measurements, we can 
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recommend clinicians and other BIA users to use BIA for body composition 
measurements despite the presence of callosities. 
InBody electrolyte wipes  
Hard and/or dry skin is a condition that was listed as a factor that could affect BIA 
measurements (31, 34). The InBody 720 manual only recommends the use of electrolyte 
wipes if an error reading arises. InBody electrolyte wipes are neither widely available nor 
often used in clinical practice. Moreover, very little information is available on its 
effectiveness in moistening hard, dry skin. Thus, determining the effect of these 
electrolyte wipes are also of clinical importance.  Since our study recruited adults with 
moderate to severe callosities, we felt that we should provide electrolyte wipes to each 
study participant to test the effect of their usage. Even though we had hypothesized that 
the usage of electrolyte wipes would have an impact on the BIA measurements, our 
results showed otherwise. Our analysis on the difference in %BF measured with 
electrolyte wipes confirmed that electrolyte wipes do not have an effect on BIA 
measurements. Based on our findings, we can conclude that electrolyte wipes do not need 
to be used on a routine basis during measurements even on individuals with callosities.  
 
Axillary pads 
This study aimed at evaluating the impact of using custom-made axillary pads on 
the measurement of percent body fat using BIA. The axillary pads were made out of 
Plastazote® foam, an inert, noninvasive material that is water resistant and non-
conductive (50). These pads were created by the Trøndelag Orthopedic Workshop and 
specifically designed for this project so that the arm posture would be held at a precise, 
standardized 15° angle. As discussed in the introduction, the InBody 720 manual does not 
specify the significance of holding the arms at a 15°angle, nor provide instructions on 
how this is to be standardized and performed. In daily practice, we have witnessed that 
clinicians do not always adhere to these guidelines and have measured their patients 
using various arm-torso angles, from acute angles formed at about 15° up to right angles 
(90°). Furthermore, we also speculated that arm posture might be of high significance 
because the excessive skin under the arms of morbid obese individuals may touch the 
trunk and interfere with the measurement. Despite manual’s instructions to hold arms out 
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at a 15° angle, the arm and trunk region might not be sufficiently separated to provide 
proper measurements of the respective body segments. We believed that improper 
measurements of these segments would therefore lead to inaccurate measurements of 
overall body composition. Therefore, we hypothesized that the use of axillary pads would 
have an impact on the reliability of BIA measurements. Knowledge on the importance of 
arm posture, especially when measuring the body composition of severely obese 
individuals using BIA is not only relevant for clinical practice, but also for future studies 
involving BIA.  
 
The evaluation of the effect of axillary pads on BIA measurements was 
warranted, as several authors expressed the need for further studies to be conducted on 
the impact of body position on BIA measurements (51, 52). Shafer and colleagues (2009) 
conducted a study on the reliability and validity of segmental multiple-frequency BIA on 
a group of healthy adults with varying BMI. They recommended further assessment be 
performed on the estimate of resistance of the trunk region. The segmental multiple-
frequency BIA instrument they used was similar to that used in our study, where the 
electrode placements on the hands and feet are distally located. The placement of the 
electrodes had given indirect, inadequate estimates of the resistance of the trunk. Shafer 
and colleagues (2009) argued further that the fat mass distribution in the obese, 
particularly, affects trunk resistivity, which in turn, might have caused the inaccurate 
measurements of the body torso. Their overall findings suggest that inaccurate body torso 
measurements might have affected their measurement of overall body composition using 
BIA.  
 
Our findings confirm our hypothesis; %BF was significantly higher when the BIA 
measurement was performed with axillary pads than without (mean difference of 1.04%). 
Similar to Shafer and colleagues’ study, our results suggest that arm posture affected the 
overall measurement of body composition using BIA. The significance of our findings is 
further strengthened by the result of our linear regression of the differences in %BF for 
the axillary pads intervention fitted with the predictor variables, where these variables 
were not shown to be highly significant in explaining the differences. BMI and gender 
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were able to explain some of the differences; however, we believe that %BF is ultimately 
higher using axillary pads because the pads prevented the excess skin and adipose tissue 
from the arms to come into contact with the trunk, and therefore allowed for a more 
precise, accurate measurement of body composition. The axillary pads also allowed the 
BIA measurements to be more standardized. The results obtained from our axillary pad 
intervention are also of great clinical significance because it helped fill the gap in 
knowledge on the importance of body position during BIA measurements and the need 
for standardization.  
 
Validity 
BIA vs. ADP 
 Many studies have assessed the validity of BIA against DEXA (36, 38, 51) while 
others have examined body composition estimates obtained by BIA and ADP and 
compared these estimates with DEXA (28, 53). Those who have compared the validity of 
BIA with DEXA have found that BIA consistently underestimates %BF in the severely 
obese (21, 22, 51). Studies comparing BIA, ADP, and DEXA have also concluded that 
BIA tends to underestimate %BF and that these methods should not be used 
interchangeably in the severely obese (53). Very few studies have assessed the validity of 
body composition estimates from BIA, in morbidly obese individuals, and compared the 
estimates with those obtained from ADP (54). 
 
The results of this study revealed that BIA has strong validity when used to 
measure body composition in severely obese adults. Percentage body fat values reported 
by BIA and ADP were not statistically significant different. This finding is consistent 
with that reported by Horie and colleagues (2008); who found that BIA and ADP’s body 
fat estimations did not differ significantly and had good accuracy and precision (54). 
However, their assessment of limits of agreement using Bland-Altman plots showed that 
they had a wide limit of agreement; thus, they concluded that standard BIA equations 
were inadequate for estimating body fat in severely obese patients. The limit of 
agreement performed in this study on the comparison of %BF values between ADP and 
BIA also depicted a large spread in agreement. Beck and colleagues (2012) conducted a 
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similar study in forty-one healthy patients  (BMI 22 ± SD 3.5) and found that BIA and 
ADP had a good within-day and between-day correlation and therefore demonstrated 
good within- and between-day agreement, despite a mean difference of 3.1% (55). Due to 
the high mean difference, the authors recommended ADP and BIA not to be used 
interchangeably. The results of our study showed that the differences in %BF were not 
statistically significant (mean difference of 0.33%); meaning that both BIA and ADP can 
be clinically used to measure body composition in the morbidly obese. However, using 
BIA and ADP interchangeably should be done with caution as our study reveals an 
inconsistency in findings with other similar studies. Further studies are needed to confirm 
our findings. 
 
Feasibility of ADP in morbid obesity 
 Air displacement plethysmography has been widely utilized in various population 
groups, including in the severely obese, and is often employed because it is user-friendly 
and has strong validity (25, 28). Petroni and colleagues (2003) assessed the feasibility of 
ADP using BodPod in nine morbidly obese patients and reported that ADP was a suitable 
method for assessing body composition in patients with BMI >40 kg/m2 (56). However, 
the results of this study do not support their findings. Although 35 out of 36 of our 
participants were successfully measured using ADP, there was one participant who was 
not physically able to enter into the chamber. This male participant had a BMI of 48.7 
and a height of 195 cm, and was not able to sit inside the chamber with the doors closed. 
The seat was too small for him, and his thighs were too long for the chamber door to 
properly close. Several of the participants who were successfully measured using ADP 
had commented on the tight space inside the chamber and expressed uncertainty prior to 
measurement. Based on our findings, we recommend that further studies conduct a 
reevaluation of the feasibility of ADP in the morbid obese demographic. The size of the 
BodPod chamber should be reassessed and altered so that it can fit people of all sizes.  
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Study limitations 
The majority of the interventions assessed in this study have never been done 
before. The target population of morbidly obese individuals with severe callosities was 
unknown. As a result, sample size calculations were difficult to perform; a small sample 
size can be considered a limitation to our study. In-depth detail of study participants’ 
medical history was also not available. Therefore, with the exception of the exclusion 
criteria, other medical conditions that may have altered the body composition 
measurements were not taken into consideration.  Despite our efforts, the standardization 
of all procedures was challenging.  For instance, no instructions were given on how to 
apply the electrolyte wipes. Some participants were successfully able to apply the 
electrolyte wipes while standing on the platform, while others had to lean on an object or 
sit down to apply the electrolyte wipes and then take a few steps to get to the InBody 720 
platform. This lack of instruction made it difficult for this study to standardize the 
measurement procedure. Furthermore, how moistened the hands and feet were and/or 
needed to be during measurement is not known. Procedures on how to standardize this 
aspect of the study had not been discussed previously. The actual arm-torso angle when 
the patient was instructed to hold a 15° without pads was also not evaluated, nor 
standardized because the InBody 720 manual does not specify how this should be 
performed. Four measurements of earlier participants also had to be excluded from 
statistical analysis because the weight of the axillary pads on BIA for these measurements 
was not properly adjusted. However, since our findings for this intervention are 
statistically significant at (p < .001), we believe that excluding their measurements did 
not affect the outcome of the intervention.  
 
The measurements pre and post pedicure were also done over a span of two days 
for ethical reasons. We had speculated that the amount of time required for each 
participant to be measured before and after the pedicure in one day in a fasted state would 
be much too long and thus, unethical. This decision, however, should not affect the 
validity or reliability of BIA measurements because BIA has been shown to have good 
between-day agreement (55). Appointments that suited the participant, the podiatrist, the 
availability of the instrument, and ethics surrounding the time frame needed to perform 
	  	   33	  
all of the measurements made it difficult for this intervention to be conducted only in one 
day. However, the consecutive two-day participation requirement made it difficult for 
this study to recruit participants. Additionally, due to scheduling difficulties, not all of the 
measurements were done in the morning. Patients had to come having fasted whenever it 
was feasible for all parties involved; thus, the timing of the measurements was not 
standardized. The time of day when the measurements were taken could have affected the 
results.  
 
 Lastly, our inclusion criteria might have been too relaxed. As mentioned earlier, 
feet severity was assessed using photographs. According to the podiatrist’s evaluation, all 
of the participants who were recruited had feet that had moderate to severe callosities and 
needed a pedicure to remove the calluses. The podiatrist had described that feet severity 
was difficult to analyze based on photographs alone, but that upon examining them the 
day of pedicure, she confirmed that her initial evaluations on the feet were correct. As 
previously discussed, a known objective classification system measuring the severity of 
callosities is unavailable; thus, we had one extremely qualified podiatrist assess the 
severity of the callosities of all of the study participants. However, as described 
callosities were not always present in areas where the feet made contact with the BIA 
electrodes. Future studies should involve an initial screening by the podiatrist before 
inclusion, and include patients with callosities formed specifically on areas touching the 
BIA electrodes. However, the fact that regression analyses showed that callosity severity 
was not a predictor of %BF, strengthens our finding that the presence/absence of 
callosities does not impact significantly on %BF assessed through BIA. 
 
Recommendations for further study 
  This study’s findings on the validity of BIA compared to ADP did not confirm the 
results from previous studies, where BIA overestimated %BF in the severely obese (54, 
55). Further validity studies should be performed to strengthen our findings. We also 
recommend assessments to be made on the size and the feasibility of ADP on morbidly 
obese individuals. Axillary pads, or another form of standardization for arm posture 
should be regulated and implemented on BIA body composition measurements. 
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Standardization and better clarification of the techniques used to measure these 
individuals are warranted to strengthen the reliability of BIA measurements.  
Conclusion 
 
Overall, although not all of the results of this study are statistically significant, the 
findings from the interventions conducted are clinically relevant. The results from the 
interventions testing the impact of InBody electrolyte wipes and the effect of callosity 
removal (pedicure) were statistically insignificant, but they reveal clinically relevant 
findings: electrolyte wipes do not need to be used during measurements, and the presence 
of calluses does not seem to affect the outcome of body composition measurements. 
Through this intervention, our study has found BIA to be reliable against factors 
involving skin hydration of the hands and feet. The assessment of the validity of BIA 
compared to ADP also suggests that BIA is a valid instrument for assessing body 
composition of the severely obese. This finding implies that both BIA and ADP are valid 
methods for performing body composition measurements on the morbid obese 
population. However, the feasibility of using the ADP method on this demographic 
should be reevaluated since not all of the participants in our study were able to be 
measured using ADP. 
 
The intervention examining the effect of the custom-built axillary pads is of 
utmost clinical significance. Our finding, that %BF was higher when BIA measurements 
were performed using the axillary pads, suggests that arm posture is of extreme 
importance when measuring body composition through BIA in morbidly obese 
individuals. This finding, therefore, encourages further assessment to be done on the 
standardization of arm posture during BIA measurements, particularly on the morbid 
obese population.  
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Appendix 1. Informed consent form (English version) 
 
 
Request for participation in a clinical trial 
 
The impact of plantar callosities, arm posture, and 
use of electrolyte wipes on the reliability of body 
composition measurements by BIA in morbidly 
obese adults 
 
Background and purpose 
 
This is a request for you to participate in a research study to examine the reliability of a 
bioelectrical impedance analyzer (BIA). There are many different models of these scales that 
are available - from those that are simple, inexpensive, and are sold primarily to the general 
public, to the sophisticated machines used by clinicians and researchers. A BIA is essentially 
an advanced scale. What makes it special is its ability to distinguish fat mass from lean mass 
(muscle, bone). Values obtained from these measurements are important for those who want 
to know what body mass consists of. Nutritionists and physical trainers, for example, can use 
this data to recommend a diet or exercise regimen that would allow a person to lose weight 
without losing muscle mass. 
 
In this study, we would like to test the reliability of one of the most advanced impedance 
machines available on the market, the InBody720. Therefore, we will be evaluating 
measurements obtained using this machine while paying special attention to the role of 
callosities may have on these measurements. This machine is used daily in St. Olav 
University Hospital’s Obesity Outpatient Clinic. You have been asked to participate in this 
study because you are a patient of the Obesity Outpatient Clinic. For the purposes of this 
study, we are only recruiting obese patients. The Regional Center for Morbid Obesity 
(RSSO) at St. Olav’s University Hospital is responsible for this study.  
 
 
What does the study involve? 
 
The study entails that you meet up at the Obesity Outpatient Clinic at St. Olav’s University 
Hospital on two consecutive days having fasted. You will be weighed using BIA during both 
days. During Day 1, you will also be measured using another machine called the BodPod. 
The BodPod is also an advanced scale but measures body volume in addition. Following BIA 
and BodPod measurements on Day 1, you will receive a pedicure from the podiatrist who 
will remove the calluses and hard skin under your feet. This can take up to 1 hour.  We will 
make an appointment with the podiatrist situated 200 m away from the Obesity Outpatient 
Clinic for you so that the pedicure can take place after the measurements have been taken. 
The cost of the pedicure is covered by this study. Participation in this study involves no blood 
tests or other examinations. Study personnel will take pictures of your feet before and after 
the treatment. 
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What will happen to the measurements and your personal information?  
 
Measurement results will be analyzed by a graduate student in collaboration with researchers 
at RSSO, St. Olav's University Hospital and Faculty of Medicine, NTNU.  
Photographs of the soles of your feet are taken to evaluate skin quality, but can also be used 
in articles and seminars accompanying the study. The information documented about you 
will only be used in accordance with the purpose of the study as described above. All the data 
will be processed without name, personal identification number or other directly recognizable 
type of information. A code number links you to your data through a list of names. Only 
authorized personnel associated with the project have access to the list of names and can get 
back to you. For control purposes, the name list stored securely until 1 Dec. 2017. Then the 
list is deleted. The project leader, Bård Kulseng will be responsible for data during this 
period. Authorities that could have access to data material would include the project manager 
and the committee for misconduct in research. It will not be possible to identify you in the 
results of the study when these are published. 
 
 
Voluntary participation 
 
Participation in the study is voluntary. You can withdraw your consent to participate in the 
study at any time and without stating any particular reason. This will not bear any 
consequences for your further treatment in the Outpatient Clinic. If you wish to participate, 
sign the declaration of consent on the last page. If you wish to opt out of the study or have 
questions concerning the study, please may contact Magnus Strømmen at the RSSO by phone 
at 91 70 10 10. 
 
Further information on the study can be found in Chapter A. Further information 
about, data privacy, finance and insurance can be found in Chapter B. The 
declaration of consent follows Chapter B.  
 
 
 
 
Chapter A – Further explanation of what the study involves 
 
Criteria for participation 
 
This study is aimed at patients at the Obesity Outpatient Clinic who have moderate to 
extensive hard/thick skin on the soles (callosities). 
 
 
Examinations that study participants must undergo 
 
You must meet up at the Outpatient Clinic having fasted for two consecutive days by 
appointment. 
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Examinations will occur in this order: 
 
• Impedance measurements:  Using only undergarments, you will be standing on an 
advanced scale that will measure you for approximately two minutes per 
measurement. It is important that you stand still while the test is conducted. The 
measurements will be done several times during both days. 
 
• BodPod measurements: These measurements will only be taken on Day 1. Using 
only undergarments, you will sit inside a chamber for several minutes while sitting 
still and breathing normally.  
 
• An appointment with the podiatrist: We will schedule the appointment for you to 
remove the calluses under your feet. We will bear the expenses associated with your 
treatment. 
 
• Photographs of your feet will be taken during Day 1 and Day 2. 
 
 
Although each test will only take several minutes, you should expect to spend 1-2 hours to 
complete these examinations on Day 1, and around 30 minutes on Day 2. You will also 
receive a breakfast coupon that can be used at St. Olav’s cafés during both days upon 
completion of the measurements.    
 
 
Potential advantages and disadvantages 
 
If you choose to participate, you will receive body mass (composition) measurements using 
some of the most advanced measurement methods that are available in Norway. The BodPod 
machine used in this study is considered as the most reliable machine in practical use and is 
the only one available in Norway. You will also receive a free pedicure and free breakfasts 
for two days. Many of our patients at the Outpatient Clinic struggle with calluses under the 
feet and are prone to complications associated with callosities and may benefit from 
receiving the pedicure. We are not aware of any disadvantages or risks associated with 
participating in this study. 
 
 
 
Chapter B – Data privacy, funding, and insurance 
 
 
Data privacy 
 
Information collected on you will primarily be weight data (body weight, fat mass, fat-free 
mass), height, weight, and age. We will also document the pictures we take of your feet. 
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Releasing material and data to other parties 
 
If you agree to participate in the study, you also consent to testing and non-identifiable data 
(described above) to be given to the graduate student to perform the analyses and her 
supervisors at St. Olav's Hospital and Faculty of Medicine at NTNU. 
 
 
Right to access and material storage  
 
If you agree to participate in the study, you are entitled to have access to the information 
registered about you. You also have the right to correct any mistakes in the information we 
have registered. If you withdraw from the study, you can request to have your collected data 
deleted, unless the information has already been used in analyses or in scientific publications. 	  
Funding and Insurance 
 
The study is funded by research grants from Helse Midt-Norge (The Central Norway 
Regional Health Authority) and NTNU. Patients are covered by the Norwegian National 
Insurance Scheme (pasientskadeerstatning) , jf Pasientskadeloven §1. 
 
 
Information about the outcome of the study 
You will receive a copy of your test results. The outcome of the study will be published in a 
scientific journal and will be linked via our website: www.stolav.no/overvekt. It may also be 
used in seminars. 
 
 
 
Consent for participation in the study 
 
 
I hereby confirm that I am willing to participate in the study.  
 
 
------------------------------------------------------------------------------------------------------------ 
(Signed by the study participant, date) 
 
 
 
 
I hereby confirm that I have given information about the study. 
 
 
------------------------------------------------------------------------------------------------------------ 
(Signed, role in the study, date) 
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Appendix 2. Informed consent form (Norwegian version) 
 
Forespørsel om deltakelse i forskningsprosjektet 
 
Betydningen av fotkallositeter, arm positur, og bruk 
av elektrolytt servietter for påliteligheten av 
kroppsmassemåling utført med bioelektrisk 
impedans analyse hos sykelig overvektige voksne 
	  
Bakgrunn	  og	  hensikt	  
 
Dette er en henvendelse til deg om å delta i en forskningsstudie for å undersøke påliteligheten 
av impedansmaskiner. Det finnes mange ulike modeller av slike maskiner, fra de helt enkle 
og rimelige solgt primært til private for bruk på baderommet, til avanserte maskiner brukt av 
klinikere og forskere. 
 
En impedansmaskin er i grunnen en avansert badevekt. Det som gjør den spesiell er at den 
skiller mellom fettmasse og fettfri masse (muskler, knokler). Slik gir den verdifull 
informasjon for mennesker som ønsker å vite hva kroppsmassen består i, eksempelvis ved 
dietter eller trening hvor det er vesentlig å gå ned i vekt uten å tape særlig muskelmasse. 
 
I denne studien ønsker vi å teste påliteligheten ved en av de mest avanserte 
impedansmaskinene på markedet. Denne er i daglig bruk ved Obesitaspoliklinikken på St. 
Olavs Hospital. Mer eksakt ønsker vi å undersøke betydningen hard hud under føttene har for 
måleresultatet. 
 
Du blir spurt om å delta fordi du er pasient ved Obesitaspoliklinikken. I denne studien 
henvender vi oss kun til overvektige. 
 
Ansvarlig for studien er Regionalt senter for sykelig overvekt ved St. Olavs Hospital. 
 
Hva innebærer studien? 
 
Studien innebærer at du må møte fastende fra morgenen ved Obesitaspoliklinikken på to 
påfølgende dager. Begge dagene vil du bli veid med impedansmaskinen. Den ene dagen vil 
du i tillegg bli testet i en annen maskin kalt BodPod. Dette er også en slags avansert vekt, 
men som i tillegg måler volumet av kroppen. 
 
På Dag 1 vil du i tillegg få behandling hos fotterapeut. Fotterapeuten vil da fjerne hard hud 
under føttene dine (pedikyr). Dette kan ta opptil 1 time. Vi vil gjøre avtale med fotterapeuten 
for deg slik at dette kan taes etter testingen på Dag 1. Fotterapeuten holder til 200 m unna 
Obesitaspoliklinikken. Behandlingen dekkes av prosjektet og skal derfor ikke koste deg noe. 
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Å delta i studien innebærer ingen blodprøver eller andre undersøkelser. Men det vil bli tatt 
bilder av føttene dine før og etter behandlingen hos fotterapeut. 
 
Mulige fordeler og ulemper 
 
Fordelene med å delta er at du vil få en grundig måling av kroppsmasse utført med BodPod. 
Maskinen er regnet som den mest pålitelige i praktisk bruk og er den eneste i Norge. En 
annen fordel er at du får gratis fotpleie. Mange av våre pasienter sliter med hard hud under 
føttene og er utsatt for komplikasjoner grunnet dette. 
 
Vi er ikke kjent med at det er ulemper eller risiko knyttet til å delta i studien. 
 
Hva skjer med informasjonen om deg? 
 
Måleresultatene vil bli analysert av en mastergradsstudent i samarbeid med forskere ved 
Regionalt senter for sykelig overvekt, St. Olavs Hospital og Det medisinske fakultet, NTNU. 
Fotografi av fotsålen taes for å vurdere hudens kvalitet, men vil også kunne brukes i 
artikler/foredrag som følger av studien. 
 
Informasjonen som registreres om deg skal kun brukes slik som beskrevet i hensikten med 
studien. Alle opplysningene vil bli behandlet uten navn og fødselsnummer eller andre direkte 
gjenkjennende opplysninger. En kode knytter deg til dine opplysninger og prøver gjennom en 
navneliste.  
 
Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og som 
kan finne tilbake til deg. Av kontrollhensyn blir navnelisten oppbevart forsvarlig frem til 1. 
des. 2017. Deretter blir listen slettet. Det er prosjektleder Bård Kulseng som er ansvarlig for 
datamaterialet i denne perioden. Instanser som kan tenkes å kontrollere grunnlagsmaterialet 
er f.eks. forskningsansvarlige og Uredelighetsutvalget for forskning. 
 
Det vil ikke være mulig å identifisere deg i resultatene av studien når disse publiseres. 
 
Frivillig deltakelse 
 
Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn trekke ditt 
samtykke til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling i 
poliklinikken. Dersom du ønsker å delta, undertegner du samtykkeerklæringen på siste side. 
Om du nå sier ja til å delta, kan du senere trekke tilbake ditt samtykke uten at det påvirker din 
øvrige behandling. Dersom du senere ønsker å trekke deg eller har spørsmål til studien, kan 
du kontakte Magnus Strømmen ved Regionalt senter for sykelig overvekt på telefon 91 70 10 
10. 
  
Ytterligere informasjon om studien finnes i kapittel A. 
Ytterligere informasjon om personvern og forsikring finnes i kapittel B 
Samtykkeerklæring følger etter kapittel B. 
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Kapittel A- utdypende forklaring av hva studien innebærer 
 
Kriterier for deltakelse 
 
Studien henvender seg til pasienter ved Obesitaspoliklinikken og som har moderat til 
omfattende hard/tykk hud på fotsålene. 
  
Undersøkelser du må gjennom 
 
Du må møte fastende i Obesitaspoliklinikken to påfølgende dager etter nærmere avtale. Dette 
skal du gjennom: 
 
• Impedansmåling: Dette er i praksis å stå på en slags avansert vekt. Det er viktig at du 
står rolig mens testen kjøres, noe som vil ta omtrent to minutter. Testen vil bli gjort 
gjentatte ganger begge dagene. Veiingen vil bli gjort i undertøy. 
 
• BodPod-måling: Denne testen kjøres kun en av dagene. Den innebærer at du sitter 
inne i et kammer et par minutters tid. Testen kjøres i undertøy. 
 
• Time hos fotterapeut: Vi bestiller time for deg. Behandlingen hos fotterapeut er betalt 
av oss. 
 
• Fotografi av fotsålene. Bilder kan bli tatt både på Dag 1 og Dag 2. 
 
Selv om hver enkelt test i seg selv kun tar et par minutters tid, må du i verste fall påregne 1-2 
timer for å få alt dette unnagjort. Timen hos fotterapeut på Dag 1 kommer i tillegg. Du vil 
også få betalt frokost av oss etter målingene er unnagjort. 
 
Mulige fordeler 
 
Om du velger å delta vil du få målt din kroppsmasse ved hjelp av de mest avanserte 
målemetodene som finnes tilgjengelig i Norge i dag. Du vil også få gratis fotpleie. 
 
Mulige ulemper 
 
Vi kjenner ikke til at det er ulemper knyttet til å delta. 
 
 
Kapittel B - Personvern, biobank, økonomi og forsikring 
	  
Personvern 	  
Opplysninger som registreres om deg er først og fremst vektdata (kroppsvekt, fettmasse, 
fettfri masse). Dernest registrerer vi fotografier av fotsålen. 
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St. Olavs Hospital ved administrerende direktør er databehandlingsansvarlig. Studien er 
godkjent av Regionalt komité for medisinsk og helsefaglig forskningsetikk. 
	  
Utlevering av materiale og opplysninger til andre 	  
Hvis du sier ja til å delta i studien, gir du også ditt samtykke til at prøver og avidentifiserte 
opplysninger (beskrevet ovenfor) utleveres til masterstudenten som skal gjøre analysene og 
hennes veiledere ved St. Olavs Hospital og Det medisinske fakultet ved NTNU. 
	  
Rett til innsyn og sletting av opplysninger om deg og sletting av prøver  	  
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er 
registrert om deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har 
registrert. Dersom du trekker deg fra studien, kan du kreve å få slettet innsamlede prøver og 
opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i 
vitenskapelige publikasjoner.  
 
Økonomi 	  
Studien er finansiert gjennom forskningsmidler fra Helse Midt-Norge og NTNU. 
 
Forsikring 
 
Pasientene omfattes av Norsk pasientskadeerstatning, jf Pasientskadeloven §1. 
 
Informasjon om utfallet av studien 	  
Du vil få kopi av dine egne måleresultater. Utfallet av undersøkelsen blir publisert i et 
vitenskaplig tidsskrift og vil bli lenket til via vår hjemmeside: www.stolav.no/overvekt.  
Det kan også bli kunngjort i foredrag. 
	  
Samtykke til deltakelse i studien 
 
 
Jeg er villig til å delta i studien  
 
 
------------------------------------------------------------------------------------------------------------ 
(Signert av prosjektdeltaker, dato) 
 
 
 
Jeg bekrefter å ha gitt informasjon om studien 
 
 
------------------------------------------------------------------------------------------------------------ 
(Signert, rolle i studien, dato)  
